Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Oct
16
2018
Major Drug Company Settles Deceptive Co-Pay Coupon Class in New York Clifford Law Offices
Oct
16
2018
New Draft Guidance on Adaptive Designs for Clinical Trials Epstein Becker & Green, P.C.
Oct
16
2018
New OSHA Guidance: Certain Safety Incentive Programs, Post-Accident Drug Tests Permissible Jackson Lewis P.C.
Oct
16
2018
Washington and Oregon to Vote on Soda and Food Tax Bans Keller and Heckman LLP
Oct
15
2018
“Clarification” of Border Crossing Rules Raises More Questions for Canadian Cannabis Industry Wilson Elser Moskowitz Edelman & Dicker LLP
Oct
15
2018
ML Strategies Health Care Preview Week of October 15 Mintz
Oct
15
2018
Survey Assessing Level of Consumer Confusion Over Whether Plant-Based Products and Dairy Products Contain Cow’s Milk Keller and Heckman LLP
Oct
13
2018
EU-OSHA Posts Info Sheet on Manufactured Nanomaterials in the Workplace Bergeson & Campbell, P.C.
Oct
12
2018
Police Officer’s Disclosure of Adderall Prescription Insufficient to Support Disability Discrimination Claim Jackson Lewis P.C.
Oct
12
2018
TTB Publishes Updated Guidelines for Formula Approvals for Domestic Producers and Importers McDermott Will & Emery
Oct
12
2018
What “Bio-based” Means Across The Globe Bergeson & Campbell, P.C.
Oct
12
2018
Germany Publishes Study on Health Effects of Ultrafine Particles Bergeson & Campbell, P.C.
Oct
11
2018
FDA Issues Draft Guidance on Expanding Special 510(K) Program Barnes & Thornburg LLP
Oct
11
2018
USDA Secretary Signals USDA Role Over Animal Cell Culture Technology Regulation Ahead of Joint USDA-FDA Meeting Keller and Heckman LLP
Oct
10
2018
EPA Publishes SNUR for Single-Walled Carbon Nanotubes Bergeson & Campbell, P.C.
Oct
10
2018
FDA Adds Eight New Substances to its Inventory of Effective FCS Notifications - October 2018 Keller and Heckman LLP
Oct
10
2018
FDA Removes Clearance for Styrene and Other Synthetic Flavoring Substances Keller and Heckman LLP
Oct
10
2018
Flavored Sparkling Water, LaCroix, Sued Over Natural Claims Keller and Heckman LLP
Oct
9
2018
Sunshine Act Expands to Advance Practice Nurses and Physician Assistants Mintz
Oct
9
2018
Celebrating the Promise of Parity and the Path Forward Mintz
Oct
9
2018
Canada’s New Regulatory Framework for Vaping Products Keller and Heckman LLP
Oct
9
2018
FDA Removes Clearance for 7 Synthetic Flavoring Substances Keller and Heckman LLP
Oct
8
2018
California Adopts Statewide Producer-Funded Pharmaceutical Household Drug and Sharps Take-Back Program Beveridge & Diamond PC
Oct
8
2018
New CBMA Guidance Further Clarifies Excise Tax Rules for Imported Beverages McDermott Will & Emery
Oct
8
2018
Health Care Enforcement Quarterly Roundup - October 2018 McDermott Will & Emery
Oct
6
2018
The New Jersey Supreme Court’s Latest Decision Affecting Pharmaceutical Multicounty Litigation Stark & Stark
Oct
5
2018
MERCOSUR Revised Resolution on Additives for Plastic FCMs in Final Review Keller and Heckman LLP
Oct
5
2018
DEA Schedules a FDA-Approved CBD Drug McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins